NovoCure's Q1 beat, Optune Lua momentum, and global expansion signal strong growth ahead. Find out why NVCR stock is a buy.

Nvidia Corporation's Q1 earnings are coming May 28th—explore their AI growth, business outlook, valuation, and risks. Click ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” first-quarter 2025 investor ...

Baidu, Inc. reported strong Q1 results, but soft advertising revenue weighed on stock performance. Click here to find out why ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” first-quarter 2025 investor ...

Xcel Energy Inc. (NASDAQ:XEL) announced on May 21 that its Board of Directors approved a quarterly dividend of 57 cents per share. This is a 4.1% increase from the previous amount, 54.75 cents. The ...

The two primary factors that lead me to make decisions in the U.S. bond market and for U.S. currency are both going up.” ...

The S&P 500 is making its way back up from a tariff-included plummet, but not all of its stocks are doing as well. Amazon ( ...

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...

Recurve Capital, an investment management company, released its first-quarter 2025 investor letter. The first quarter was a ...

Quality’s surprising underperformance in 2025 proves that even in risk-off periods, valuation matters. Many wonder if this perpetually out-of-favor asset class is worth the trouble. Hampton: And which ...

Vertex Pharmaceuticals has solid revenue projections for its CF franchise, and a promising drug pipeline, especially in pain.